To evaluate the impact of population immunity of the efficacy of malaria interventions and evaluating the impact of intervention programs on host immunity and patterns of disease.
- To develop sero-markers for population studies
- To define malaria exposure and transmission intensity
- To understand the dynamics of naturally acquired immunity in children and pregnant women and how they relate To patterns of disease.
Our group centres on malaria immuno-epidemiology and focuses on developing and utilising immunological biomarkers for vaccine trials, disease surveillance and evaluating the impact of interventions for malaria.
We participate in numerous population studies in malaria-endemic countries, such as Kenya, Papua New Guinea and Thailand, through collaborations with national research institutes based in those countries.
Vaccine trials
Disease surveillance
Evaluation
of the impact of interventions for malaria.
Working
Group
Meet the working group. Together, we are translating research into better health, for all.
